Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.
Clinical trial NCT01711853 · COMPLETED
Trial details
- NCT number
- NCT01711853
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2013-12-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.